211 related articles for article (PubMed ID: 34070531)
21. Mutations of the Smad4 gene in acute myelogeneous leukemia and their functional implications in leukemogenesis.
Imai Y; Kurokawa M; Izutsu K; Hangaishi A; Maki K; Ogawa S; Chiba S; Mitani K; Hirai H
Oncogene; 2001 Jan; 20(1):88-96. PubMed ID: 11244507
[TBL] [Abstract][Full Text] [Related]
22. Tumor-derived C-terminal mutations of Smad4 with decreased DNA binding activity and enhanced intramolecular interaction.
Kuang C; Chen Y
Oncogene; 2004 Feb; 23(5):1021-9. PubMed ID: 14647410
[TBL] [Abstract][Full Text] [Related]
23. Hypomorph mutation-directed small-molecule protein-protein interaction inducers to restore mutant SMAD4-suppressed TGF-β signaling.
Tang C; Mo X; Niu Q; Wahafu A; Yang X; Qui M; Ivanov AA; Du Y; Fu H
Cell Chem Biol; 2021 May; 28(5):636-647.e5. PubMed ID: 33326750
[TBL] [Abstract][Full Text] [Related]
24. TGF-β/SMAD4 signaling pathway activates the HAS2-HA system to regulate granulosa cell state.
Li X; Du X; Yao W; Pan Z; Li Q
J Cell Physiol; 2020 Mar; 235(3):2260-2272. PubMed ID: 31489963
[TBL] [Abstract][Full Text] [Related]
25. Smad signaling pathway is a pivotal component of tissue inhibitor of metalloproteinases-3 regulation by transforming growth factor beta in human chondrocytes.
Qureshi HY; Ricci G; Zafarullah M
Biochim Biophys Acta; 2008 Sep; 1783(9):1605-12. PubMed ID: 18471442
[TBL] [Abstract][Full Text] [Related]
26. Identification of the gene transcription and apoptosis mediated by TGF-beta-Smad2/3-Smad4 signaling.
Yu J; Zhang L; Chen A; Xiang G; Wang Y; Wu J; Mitchelson K; Cheng J; Zhou Y
J Cell Physiol; 2008 May; 215(2):422-33. PubMed ID: 17960585
[TBL] [Abstract][Full Text] [Related]
27. Dynamic regulation of Tgf-B signaling by Tif1γ: a computational approach.
Andrieux G; Fattet L; Le Borgne M; Rimokh R; Théret N
PLoS One; 2012; 7(3):e33761. PubMed ID: 22461896
[TBL] [Abstract][Full Text] [Related]
28. MiRNA-34a reversed TGF-β-induced epithelial-mesenchymal transition via suppression of SMAD4 in NPC cells.
Huang G; Du MY; Zhu H; Zhang N; Lu ZW; Qian LX; Zhang W; Tian X; He X; Yin L
Biomed Pharmacother; 2018 Oct; 106():217-224. PubMed ID: 29960168
[TBL] [Abstract][Full Text] [Related]
29. Par-4 mediated Smad4 induction in PDAC cells restores canonical TGF-β/ Smad4 axis driving the cells towards lethal EMT.
Mohd Faheem M; Rasool RU; Ahmad SM; Jamwal VL; Chakraborty S; Katoch A; Gandhi SG; Bhagat M; Goswami A
Eur J Cell Biol; 2020 May; 99(4):151076. PubMed ID: 32439219
[TBL] [Abstract][Full Text] [Related]
30. TGF-β receptor inhibitor LY2109761 enhances the radiosensitivity of gastric cancer by inactivating the TGF-β/SMAD4 signaling pathway.
Yang T; Huang T; Zhang D; Wang M; Wu B; Shang Y; Sattar S; Ding L; Liu Y; Jiang H; Liang Y; Zhou F; Wei Y
Aging (Albany NY); 2019 Oct; 11(20):8892-8910. PubMed ID: 31631064
[TBL] [Abstract][Full Text] [Related]
31. Wip1 regulates Smad4 phosphorylation and inhibits TGF-β signaling.
Park DS; Yoon GH; Kim EY; Lee T; Kim K; Lee PC; Chang EJ; Choi SC
EMBO Rep; 2020 May; 21(5):e48693. PubMed ID: 32103600
[TBL] [Abstract][Full Text] [Related]
32. Novel tumor suppressive function of Smad4 in serum starvation-induced cell death through PAK1-PUMA pathway.
Lee SH; Jung YS; Chung JY; Oh AY; Lee SJ; Choi DH; Jang SM; Jang KS; Paik SS; Ha NC; Park BJ
Cell Death Dis; 2011 Dec; 2(12):e235. PubMed ID: 22130069
[TBL] [Abstract][Full Text] [Related]
33. The murine gastrin promoter is synergistically activated by transforming growth factor-beta/Smad and Wnt signaling pathways.
Lei S; Dubeykovskiy A; Chakladar A; Wojtukiewicz L; Wang TC
J Biol Chem; 2004 Oct; 279(41):42492-502. PubMed ID: 15292219
[TBL] [Abstract][Full Text] [Related]
34. Repression of Smad4 by miR‑205 moderates TGF-β-induced epithelial-mesenchymal transition in A549 cell lines.
Zeng Y; Zhu J; Shen D; Qin H; Lei Z; Li W; Huang JA; Liu Z
Int J Oncol; 2016 Aug; 49(2):700-8. PubMed ID: 27279345
[TBL] [Abstract][Full Text] [Related]
35. TGF-β-activated SMAD3/4 complex transcriptionally upregulates N-cadherin expression in non-small cell lung cancer.
Yang H; Wang L; Zhao J; Chen Y; Lei Z; Liu X; Xia W; Guo L; Zhang HT
Lung Cancer; 2015 Mar; 87(3):249-57. PubMed ID: 25595426
[TBL] [Abstract][Full Text] [Related]
36. PRMT5 methylating SMAD4 activates TGF-β signaling and promotes colorectal cancer metastasis.
Liu A; Yu C; Qiu C; Wu Q; Huang C; Li X; She X; Wan K; Liu L; Li M; Wang Z; Chen Y; Hu F; Song D; Li K; Zhao C; Deng H; Sun X; Xu F; Lai S; Luo X; Hu J; Wang G
Oncogene; 2023 May; 42(19):1572-1584. PubMed ID: 36991117
[TBL] [Abstract][Full Text] [Related]
37. Nuclear targeting of transforming growth factor-beta-activated Smad complexes.
Chen HB; Rud JG; Lin K; Xu L
J Biol Chem; 2005 Jun; 280(22):21329-36. PubMed ID: 15799969
[TBL] [Abstract][Full Text] [Related]
38. BCL6 represses Smad signaling in transforming growth factor-beta resistance.
Wang D; Long J; Dai F; Liang M; Feng XH; Lin X
Cancer Res; 2008 Feb; 68(3):783-9. PubMed ID: 18245479
[TBL] [Abstract][Full Text] [Related]
39. BRCA1 regulates transforming growth factor-β (TGF-β1) signaling through Gadd45a by enhancing the protein stability of Smad4.
Li D; Kang N; Ji J; Zhan Q
Mol Oncol; 2015 Oct; 9(8):1655-66. PubMed ID: 26022109
[TBL] [Abstract][Full Text] [Related]
40. Signaling through the Smad pathway by insulin-like growth factor-binding protein-3 in breast cancer cells. Relationship to transforming growth factor-beta 1 signaling.
Fanayan S; Firth SM; Baxter RC
J Biol Chem; 2002 Mar; 277(9):7255-61. PubMed ID: 11751851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
